Cyclerion Therapeutics (CYCN) Accounts Payables (2019 - 2025)
Historic Accounts Payables for Cyclerion Therapeutics (CYCN) over the last 7 years, with Q3 2025 value amounting to $480000.0.
- Cyclerion Therapeutics' Accounts Payables rose 5789.47% to $480000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $480000.0, marking a year-over-year increase of 5789.47%. This contributed to the annual value of $390000.0 for FY2024, which is 6744.57% down from last year.
- Cyclerion Therapeutics' Accounts Payables amounted to $480000.0 in Q3 2025, which was up 5789.47% from $462000.0 recorded in Q2 2025.
- Over the past 5 years, Cyclerion Therapeutics' Accounts Payables peaked at $3.9 million during Q1 2023, and registered a low of $304000.0 during Q3 2024.
- For the 5-year period, Cyclerion Therapeutics' Accounts Payables averaged around $1.4 million, with its median value being $1.2 million (2021).
- In the last 5 years, Cyclerion Therapeutics' Accounts Payables soared by 13004.57% in 2022 and then crashed by 8112.1% in 2024.
- Cyclerion Therapeutics' Accounts Payables (Quarter) stood at $1.8 million in 2021, then skyrocketed by 62.47% to $3.0 million in 2022, then crashed by 59.66% to $1.2 million in 2023, then tumbled by 67.45% to $390000.0 in 2024, then increased by 23.08% to $480000.0 in 2025.
- Its Accounts Payables was $480000.0 in Q3 2025, compared to $462000.0 in Q2 2025 and $483000.0 in Q1 2025.